Such a good post to remind us of what could be. My wife is a physiotherapist in an orthopaedic ward of a hospital so sees a lot of the joint replacement patients in Hobart. She talks about the amount of TKRs that probably aren't even necessary going through the system because the patient thinks it is the easiest option rather than weight loss and strengthening through exercise etc. Zilosul could fit as perfect step before surgery for all of these patients as an easier first option to try. With worse case scenario of not receiving dmoad labelling, I think the sales figures are still quite conservative.. My wife has said repeatedly that if iPPS works as a lot of us suspect then she would be pretty much out of a job. Luckily we have enough PAR shares as insurance for that!
PAR Price at posting:
$1.22 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)